Allergan, the maker of BOTOX announced the launch and availability of its next-generation hyaluronic acid (HA) dermal filler formulation, JUVEDERM in India.
JUVEDERM, which stands for "Extra Comfort", contains the local anesthetic lidocaine to provide patients with enhanced comfort during treatment.
Approved by the U.S. Food and Drug Administration (FDA) in January 2010, JUVEDERM is the first and only smooth-consistency HA dermal filler formulated with lidocaine to smooth the "parentheses" - facial wrinkles around the nose and mouth - for up to one year with just one treatment. JUVEDERM currently holds the No. 1 position in the worldwide facial filler market.1
The latest advancement in HA dermal filler, JUVEDERM was launched in the presence of India's leading aesthetic physicians Dr Jamuna Pai, Dr Simal Soin, Dr Vandana Chatrath, Dr Chiranjiv Chhabra, Dr Swati Srivastav, Dr Kuldeep Singh and Dr Hema Pant and well-known Former Miss World Diana Hayden. Dr Jamuna Pai, Cosmetologist, 'Blush', said "As a physician, my priority is to ensure the best outcomes for my patients, as well as their comfort level during the injection.
Previously it often took up to 30 minutes for an anesthetic block to take effect and an almost similar amount of time to reassure the patient. Now, with JUVEDERM, patients can enjoy a more comfortable injection experience and possibly less time in the clinic. Its formulation with 0.3% preservative-free lidocaine numbs the treatment area within seconds, potentially reducing the need for an additional anesthetic. Patients can receive the same smooth, long-lasting and natural-looking results demonstrated with existing formulations of JUVEDERM."
While launching the new product, Diana Hayden added "Today, feeling good is about looking good and this requires effort. Thanks to revolutionary products such as JUVEDERM, people have better options to restore their youthful looks in a more relaxed and comforting manner."
LinkWithin
